Home > Boards > US Listed > Medical - Drugs > Altimmune, Inc (ALT)

If there is a PR in the morning

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
chuckt880 Member Profile
 
Followed By 2
Posts 311
Boards Moderated 0
Alias Born 04/09/18
160x600 placeholder
Altimmune to Present at Upcoming H.C. Wainwright Investor Conferences October 12-13, 2021 GlobeNewswire Inc. - 10/6/2021 4:01:00 PM
Altimmune Announces Initiation of 12-week Phase 1b Trial of Pemvidutide in Subjects with Non-Alcoholic Fatty Liver Disease GlobeNewswire Inc. - 10/4/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2021 7:01:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2021 7:01:40 PM
Altimmune to Host Key Opinion Leader Call with Dr. Stephen Harrison on Pemvidutide Phase 1 Clinical Trial Results on September 30, 2021 GlobeNewswire Inc. - 9/29/2021 6:15:00 PM
Sonoma Pharmaceuticals, Evelo Biosciences leads healthcare gainers; Altimmune, InMode among major losers Seeking Alpha - 9/28/2021 10:57:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/28/2021 7:11:48 AM
Altimmune Announces Positive Results From 12-week Phase 1 Clinical Trial of ALT-801 (Pemvidutide) in Overweight and Obese Volunteers GlobeNewswire Inc. - 9/28/2021 7:01:00 AM
Altimmune to Announce 12-Week Data From ALT-801 Phase 1 Trial on September 28, 2021 GlobeNewswire Inc. - 9/27/2021 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2021 5:27:09 PM
Altimmune to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 GlobeNewswire Inc. - 9/7/2021 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/31/2021 7:01:17 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/31/2021 11:04:29 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/16/2021 5:07:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2021 4:08:14 PM
Altimmune Announces Second Quarter 2021 Financial Results and Provides a Corporate Update GlobeNewswire Inc. - 8/10/2021 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/6/2021 7:02:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/6/2021 7:01:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/6/2021 7:01:06 PM
Altimmune to Announce Second Quarter 2021 Financial Results on August 11, 2021 GlobeNewswire Inc. - 8/4/2021 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/2/2021 7:01:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 7:02:01 PM
Altimmune Not Immune to Poor Results; Drops AdCOVID Vaccine program TipRanks - 6/30/2021 5:46:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/29/2021 4:31:17 PM
Altimmune to scrap COVID-19 vaccine program after "disappointing" results Seeking Alpha - 6/29/2021 4:15:56 PM
chuckt880   Tuesday, 05/26/20 06:46:48 PM
Re: BKuhar33 post# 1358
Post # of 1498 
If there is a PR in the morning shorts are so screwed. This will pop before they have any chance to get out.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences